iBio, Inc. IBIO
NASDAQ IBIO
$0.77 -0.05 (-6.58%)
As of: Nov 12, 2026 · 10:25 AM EST

iBio (IBIO) Return on Sales [ROS] (2009 - 2026)

Updated

iBio (IBIO) reported Return on Sales [ROS] of -35141.00% for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 32542.00 percentage points from -2599.00% a year earlier and down 25488.00 percentage points from the prior quarter.

Analysis

iBio (IBIO) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

Dating back to fiscal Q3 2011, iBio's Return on Sales [ROS] record includes 60 quarters.

  • Return on Sales [ROS] has a five-year change of -33828.85 percentage points (FY2021 to FY2026).
  • By fiscal year, Return on Sales [ROS] came in at -4650.50% in FY2025 (+2742.39 pp), -7392.89% in FY2024 and -1576.27% in FY2022 (-264.13 pp).
  • The fiscal Q4 2026 figure ranks as the lowest quarterly Return on Sales [ROS] since fiscal Q3 2024.
  • Year over year, Return on Sales [ROS] has now declined in each of the last three quarters, with an average year-over-year change of +3845.50 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Sales [ROS] in five years was fiscal Q2 2025 (a gain of 39256.50 percentage points); the low point was fiscal Q2 2024 (a drop of 39496.56 percentage points).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at -9653.00% (Q3 2026), -8491.00% (Q2 2026) and -5951.00% (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 iBio 118.23 Mn -174.02 Mn - -775.63%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -775.63%
Jun 30, 2026 -35,141.00%
Mar 31, 2026 -9,653.00%
Dec 31, 2025 -8,491.00%
Sep 30, 2025 -5,951.00%
Jun 30, 2025 -2,599.00%
Mar 31, 2025 -4,483.47%
Dec 31, 2024 -2,209.50%
Sep 30, 2024 -8,935.43%
Jun 30, 2024 -1,948.00%
Mar 31, 2024 -36,380.00%
Dec 31, 2023 -41,466.00%
Sep 30, 2023 -10,206.00%
Dec 31, 2022 -1,969.44%
Sep 30, 2022 -1,783.78%
Jun 30, 2022 -1,576.27%
Mar 31, 2022 -377.11%
Dec 31, 2021 -2,171.49%
Sep 30, 2021 -6,220.24%
Jun 30, 2021 -1,922.40%
API Access

iBio Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=IBIO&period=max&api_key=YOUR_API_KEY